Zhong, Weina
Benissan-Messan, Dathe Z.
Ma, Jianjie
Cai, Chuanxi http://orcid.org/0000-0003-0532-7435
Lee, Peter H. U.
Funding for this research was provided by:
National Institute of General Medical Sciences (5K08GM126315)
American Heart Association (18TPA34170188)
National Institute on Aging (AG056919)
Article History
Received: 29 April 2021
Accepted: 11 June 2021
First Online: 28 June 2021
Declarations
:
: All authors have their consent to participate.
: All authors agree to publish this manuscript.
: JM hold equity interest in TRIM-edicine, Inc., a university spin-off biotechnology company that develops MG53 for regenerative medicine application. Rutgers University and Ohio State University own the Intellectual property related to MG53. All the other authors declare that they have no competing interests.